Role of syndecan-4 in breast cancer pathophysiology.


Journal

American journal of physiology. Cell physiology
ISSN: 1522-1563
Titre abrégé: Am J Physiol Cell Physiol
Pays: United States
ID NLM: 100901225

Informations de publication

Date de publication:
01 11 2022
Historique:
pubmed: 13 9 2022
medline: 22 10 2022
entrez: 12 9 2022
Statut: ppublish

Résumé

Expression of the cell surface heparan sulfate proteoglycan syndecan-4 is dysregulated in breast cancer, the most frequent malignancy in women. High expression of syndecan-4 correlates with a worse survival in the subgroup of estrogen receptor negative and estrogen/progesterone-receptor negative patients. Aberrant expression of syndecan-4 in breast cancer involves both transcriptional and posttranscriptional mechanisms, including estrogen- and growth factor-dependent regulation, mutations in

Identifiants

pubmed: 36094435
doi: 10.1152/ajpcell.00152.2022
doi:

Substances chimiques

Syndecan-4 0
Heparan Sulfate Proteoglycans 0
Zoledronic Acid 6XC1PAD3KF
Progesterone 4G7DS2Q64Y
Ligands 0
Receptors, Estrogen 0
Extracellular Matrix Proteins 0
MicroRNAs 0
Intercellular Signaling Peptides and Proteins 0
Trastuzumab P188ANX8CK
Integrins 0
Estrogens 0
Syndecan-1 0
NUP153 protein, human 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

C1345-C1354

Auteurs

Jessica Oyie Sousa Onyeisi (JOS)

Department of Gynecology and Obstetrics, Münster University Hospital, Munster, Germany.
Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, Sao Paulo, Brazil.

Carla Cristina Lopes (CC)

Disciplina de Biologia Molecular, Departamento de Bioquímica, Universidade Federal de São Paulo, Sao Paulo, Brazil.
Departamento de Ciências Biológicas, Instituto de Ciências Ambientais, Químicas e Farmacêuticas, Universidade Federal de São Paulo, Sao Paulo, Brazil.

Martin Götte (M)

Department of Gynecology and Obstetrics, Münster University Hospital, Munster, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH